Policy paper
Amendment to the Health Service Branded Medicines (Control of Prices and Supply of Information) (No. 2) Regulations 2008
Amendment to the Health Service Branded Medicines (Control of Prices and Supply of Information) (No. 2) Regulations 2008.
This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government
Documents
PDF, 2.81MB, 16 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@dh.gsi.gov.uk .
Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 67.2KB, 23 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@dh.gsi.gov.uk .
Please tell us what format you need. It will help us if you say what assistive technology you use.
MS Excel Spreadsheet, 217KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@dh.gsi.gov.uk .
Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
Companies that do not belong to a voluntary scheme are subject to a statutory arrangement known as the Health Service Branded Medicines (Control of Prices and Supply of Information) (No. 2) Regulations 2008. The Secretary of State for Health has made an amendment to these regulations which came into force on 1 January 2013.
Published 18 January 2013
GOV.UK
